Table 4.
SF-36 dimensions | Time point | Laser moxibustion (n = 84) | Traditional moxibustion (n = 55) | P value* |
---|---|---|---|---|
PF (physical functioning) | Baseline | 60 (40, 70) | 60 (45, 70) | 0.713 |
Mid-term | 65 (50, 80) | 62.5 (50, 70) | ||
End of treatment | 67.5 (55, 80) | 65 (53.75, 75) | ||
Follow-up | 70 (56.25, 80) | 60 (53.75, 71.25) | ||
RP (role-physical) | Baseline | 0 (0, 50) | 25 (0, 56.25) | 0.140 |
Mid-term | 25 (0, 75) | 37.5 (0, 100) | ||
End of treatment | 25 (0, 50) | 25 (0, 75) | ||
Follow-up | 25 (0, 75) | 25 (0, 75) | ||
RE (role-emotional) | Baseline | 33.33 (0, 100) | 33.33 (0, 100) | 0.152 |
Mid-term | 33.33 (0, 100) | 66.67 (0, 100) | ||
End of treatment | 33.33 (0, 100) | 66.67 (0, 100) | ||
Follow-up | 33.33 (0, 100) | 33.33 (0, 100) | ||
VT (vitality) | Baseline | 45 (30, 55) | 55 (40, 65) | 0.006 |
Mid-term | 45 (65, 60) | 55 (45, 60) | ||
End of treatment | 50 (40, 60) | 60 (45, 70) | ||
Follow-up | 50 (35, 65) | 60 (45, 70) | ||
MH (mental health) | Baseline | 64 (48, 79) | 72 (64, 84) | 0.002 |
Mid-term | 64 (52, 76) | 72 (60, 80) | ||
End of treatment | 64 (56, 75) | 68 (60, 76) | ||
Follow-up | 68 (60, 80) | 64 (56, 80) | ||
SF (social functioning) | Baseline | 75 (62.5, 87.5) | 75 (62.5, 100) | 0.039 |
Mid-term | 75 (62.5, 87.5) | 75 (62.5, 87.5) | ||
End of treatment | 75 (62.5, 84.38) | 75 (62.5, 87.5) | ||
Follow-up | 75 (62.5, 87.5) | 75 (62.5, 87.5) | ||
BP (bodily pain) | Baseline | 55 (35, 59.38) | 67.5 (45, 67.5) | < 0.001 |
Mid-term | 57.5 (45, 67.5) | 67.5 (55, 67.5) | ||
End of treatment | 67.5 (55, 67.5) | 67.5 (57.5, 77.5) | ||
Follow-up | 67.5 (57.5, 75) | 67.5 (55, 77.5) | ||
GH (General Health) | Baseline | 35 (30, 50) | 50 (35, 60) | 0.001 |
Mid-term | 40 (30, 55) | 45 (35, 55) | ||
End of treatment | 40 (31.25, 55) | 55 (35, 65) | ||
Follow-up | 45 (35, 58.75) | 50 (45, 65) |
*P values were only presented for the comparison of baseline between the two groups